BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38365689)

  • 1. Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data.
    Revel-Vilk S; Shalev V; Gill A; Paltiel O; Manor O; Tenenbaum A; Azani L; Chodick G
    Orphanet J Rare Dis; 2024 Feb; 19(1):71. PubMed ID: 38365689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
    Mehta A; Kuter DJ; Salek SS; Belmatoug N; Bembi B; Bright J; Vom Dahl S; Deodato F; Di Rocco M; Göker-Alpan O; Hughes DA; Lukina EA; Machaczka M; Mengel E; Nagral A; Nakamura K; Narita A; Oliveri B; Pastores G; Pérez-López J; Ramaswami U; Schwartz IV; Szer J; Weinreb NJ; Zimran A
    Intern Med J; 2019 May; 49(5):578-591. PubMed ID: 30414226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks.
    Pehrsson M; Heikkinen H; Wartiovaara-Kautto U; Mäntylahti S; Bäckström P; Lassenius MI; Uusi-Rauva K; Carpén O; Elomaa K
    Mol Genet Metab Rep; 2022 Dec; 33():100911. PubMed ID: 36092251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland.
    Savolainen MJ; Karlsson A; Rohkimainen S; Toppila I; Lassenius MI; Falconi CV; Uusi-Rauva K; Elomaa K
    Mol Genet Metab Rep; 2021 Jun; 27():100725. PubMed ID: 33604241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring system to facilitate diagnosis of Gaucher disease.
    Mehta A; Rivero-Arias O; Abdelwahab M; Campbell S; McMillan A; Rolfe MJ; Bright JR; Kuter DJ
    Intern Med J; 2020 Dec; 50(12):1538-1546. PubMed ID: 33174353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.
    Pession A; Di Rocco M; Venturelli F; Tappino B; Morello W; Santoro N; Giordano P; Filippini B; Rinieri S; Russo G; Girardi K; Ruggiero A; Galea E; Antonucci R; Tovaglieri N; Porta F; Tartaglione I; Giona F; Fagioli F; Burlina A;
    Orphanet J Rare Dis; 2023 Jun; 18(1):151. PubMed ID: 37328863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional web-based survey among haematologists and gastroenterologists in Japan to identify the key factors for early diagnosis of Gaucher disease.
    Yoshimitsu M; Ono M; Inoue Y; Sagara R; Baba T; Fernandez J
    Intern Med J; 2023 Jun; 53(6):930-938. PubMed ID: 35499124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia.
    Motta I; Filocamo M; Poggiali E; Stroppiano M; Dragani A; Consonni D; Barcellini W; Gaidano G; Facchini L; Specchia G; Cappellini MD;
    Eur J Haematol; 2016 Apr; 96(4):352-9. PubMed ID: 26033455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P; Andersson HC; Kacena KA; Yee JD
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1.
    Machaczka M; Markuszewska-Kuczyńska A; Regenthal S; Jurczyszyn A; Gałązka K; Wahlin BE; Klimkowska M
    Pol Arch Med Wewn; 2014; 124(11):587-92. PubMed ID: 25188399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia.
    Motta I; Consonni D; Stroppiano M; Benedetto C; Cassinerio E; Tappino B; Ranalli P; Borin L; Facchini L; Patriarca A; Barcellini W; Lanza F; Filocamo M; Cappellini MD;
    Sci Rep; 2021 Jan; 11(1):2594. PubMed ID: 33510429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
    Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
    Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan.
    Ida H; Watanabe Y; Sagara R; Inoue Y; Fernandez J
    Orphanet J Rare Dis; 2022 Nov; 17(1):401. PubMed ID: 36329499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the United States.
    Wilson A; Chiorean A; Aguiar M; Sekulic D; Pavlick P; Shah N; Sniderman King L; Génin M; Rollot M; Blanchon M; Gosset S; Montmerle M; Molony C; Dumitriu A
    Orphanet J Rare Dis; 2023 Sep; 18(1):280. PubMed ID: 37689674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
    Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I Gaucher disease with bullous pemphigoid and Parkinson disease: A case report.
    Le Peillet D; Prendki V; Trombert V; Laffitte E; Assal F; Reny JL; Serratrice C
    Medicine (Baltimore); 2018 Mar; 97(13):e0188. PubMed ID: 29595653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist.
    Carubbi F; Cappellini MD; Fargion S; Fracanzani AL; Nascimbeni F
    Dig Liver Dis; 2020 Apr; 52(4):368-373. PubMed ID: 32057684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher Disease for Hematologists.
    Özdemir GN; Gündüz E
    Turk J Haematol; 2022 Jun; 39(2):136-139. PubMed ID: 35439918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: a diagnostic challenge for internists.
    Cassinerio E; Graziadei G; Poggiali E
    Eur J Intern Med; 2014 Feb; 25(2):117-24. PubMed ID: 24090739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].
    Perez Y; Belmatoug N; Bengherbia M; Yousfi K; Lioger B
    Rev Med Interne; 2023 Feb; 44(2):55-61. PubMed ID: 36669934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.